New York, NY, United States of America

Luisa F Escobar-Hoyos

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Calverton, NY (US) (2021)
  • New York, NY (US) (2022)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Luisa F Escobar-Hoyos: Pioneering Innovations in Bladder Cancer Research

Introduction

Luisa F Escobar-Hoyos is an influential inventor based in New York, NY, known for her groundbreaking work in the field of cancer research. With three patents to her name, Escobar-Hoyos has significantly contributed to the advancement of diagnostic methods for bladder cancer.

Latest Patents

One of her notable recent patents includes the innovative use of Keratin 17 as a biomarker for bladder cancer. The disclosure outlines methods for detecting and analyzing K17 expression in bladder samples obtained from subjects. It also presents methods and kits designed to identify mammalian subjects with bladder cancer by measuring K17 expression levels in samples. The methods described encompass both cell-based and cell-free techniques for evaluating keratin 17 levels in urine or bladder tissue, offering new opportunities for early detection and treatment options.

Career Highlights

Luisa has built her career through impactful roles at esteemed institutions, notably the State University of New York and Kdx Diagnostics, Inc. Her work has not only advanced academic research but has also contributed to practical applications in the medical field, emphasizing her commitment to improving patient outcomes.

Collaborations

Throughout her career, Escobar-Hoyos has collaborated with notable professionals, including Kenneth R Shroyer and Nam Hoon Kim. These partnerships have enhanced her research endeavors, leading to innovative solutions for complex medical challenges.

Conclusion

In summary, Luisa F Escobar-Hoyos stands out as a trailblazer in the realm of bladder cancer research. Her patents and collaborative efforts underscore her dedication to finding effective diagnostic methods that could significantly impact patient care. As she continues to innovate, her contributions will likely pave the way for further advancements in cancer diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…